YOLFTbeta
Inogen Inc

Inogen Inc

INGN · NASDAQ · Healthcare / Medical Devices

5.69USD+0.07 (+1.25%)

Price History

Full chart

Market Stats

Previous Close5.62
Open5.60
Day Range5.55 – 5.71
52-Week Range5.05 – 9.13
Volume238.12K
Market Cap142.25M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.91
Dividend Yield0.00%
Beta1.58
50-Day Avg5.79
200-Day Avg6.28

About

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Beverly, Massachusetts.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Kevin R. M. Smith
  • Employees753
  • Headquarters500 Cummings Center, Beverly, MA, United States, 01915, USA
  • Websitehttps://www.provider.inogen.com

Leadership

  • Mr. Kevin R. M. SmithPresident, CEO & Director · b. 1971
  • Mr. Kevin P. SmithGeneral Counsel, Secretary & Executive VP of Business Development · b. 1971
  • Ms. Jennifer Yi BoyerExecutive VP of Enterprise Enablement & Chief Human Resources Officer · b. 1975
  • Mr. Jason A. RichardsonCFO, Executive VP & Treasurer · b. 1977
  • Mr. Andrew P. RedingExecutive VP & COO · b. 1970
  • Ms. Mary WrightVP & Chief Accounting Officer · b. 1987
  • Mr. Naga RameswamyChief Technology Officer
  • Ms. Lorna WilliamsSenior Vice President of Investor Relations
  • Mr. Dominic HultonChief Marketing Officer
  • Mr. Philip CorrinSenior Vice President of Operations & Supply Chain

Financials

Income Statement

Currency: USD2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue30.63M48.58M75.44M112.54M159.00M202.83M249.44M358.11M361.94M308.49M358.00M377.24M315.66M335.70M348.67M
Growth (%)-+58.57%+55.31%+49.17%+41.29%+27.56%+22.98%+43.57%+1.07%-14.77%+16.05%+5.37%-16.32%+6.35%+3.86%
Cost of Revenue15.93M24.63M36.45M57.02M82.75M105.52M128.20M179.53M190.08M170.31M181.52M223.71M188.96M180.96M182.78M
Gross Profit14.70M23.95M38.99M55.52M76.26M97.31M121.24M178.58M171.86M138.18M176.48M153.53M126.70M154.74M165.89M
Gross Margin48.00%49.30%51.68%49.33%47.96%47.98%48.60%49.87%47.48%44.79%49.30%40.70%40.14%46.09%47.58%
Operating Expense16.43M23.12M34.53M45.01M61.21M74.45M93.65M140.69M152.07M150.21M167.24M238.78M236.09M197.26M196.09M
Operating Income-1.72M829.00K4.46M10.51M15.05M22.86M27.59M37.89M19.79M-12.03M9.24M-85.24M-109.39M-42.52M-30.21M
Operating Margin-5.62%1.71%5.92%9.34%9.47%11.27%11.06%10.58%5.47%-3.90%2.58%-22.60%-34.65%-12.66%-8.66%
EBITDA1.47M6.06M13.01M22.59M28.76M36.42M39.89M49.19M33.62M6.56M30.29M-9.57M-58.34M-15.47M-2.72M
EBITDA Margin4.80%12.47%17.24%20.07%18.09%17.96%15.99%13.74%9.29%2.13%8.46%-2.54%-18.48%-4.61%-0.78%
Net Income-2.00M564.00K25.43M6.83M11.59M20.52M21.00M51.84M20.95M-5.83M-6.33M-83.77M-102.45M-35.89M-22.75M
Net Income Margin-6.54%1.16%33.71%6.07%7.29%10.12%8.42%14.48%5.79%-1.89%-1.77%-22.21%-32.46%-10.69%-6.52%
R&D1.79M2.26M2.40M2.98M4.18M5.11M5.31M7.03M9.40M14.08M16.58M21.94M20.84M21.61M19.40M
R&D as % of Total Revenue5.84%4.66%3.18%2.65%2.63%2.52%2.13%1.96%2.60%4.56%4.63%5.82%6.60%6.44%5.56%
Interest Expense261.00K493.00K562.00K449.00K22.00K6.00K0018.32M25.33M21.05M2.84M---
Interest Expense % of Total Revenue0.85%1.01%0.74%0.40%0.01%0.00%0.00%0.00%5.06%8.21%5.88%0.75%---

Balance Sheet

Currency: USD2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets24.13M47.59M82.40M140.09M161.31M214.05M275.07M375.90M447.34M461.85M489.51M405.04M326.19M296.19M298.63M
Total Liabilities16.57M19.01M26.10M21.93M27.30M31.96M48.03M65.47M102.72M112.23M119.29M107.64M121.38M122.33M106.39M
Total Equity7.56M28.57M56.30M118.15M134.02M182.09M227.04M310.42M344.62M349.62M370.23M297.41M204.81M173.86M192.23M
Cash3.91M15.11M13.52M56.84M66.11M92.85M142.95M196.63M198.04M211.96M235.52M187.01M125.49M113.80M103.73M
Total Debt9.63M8.94M10.65M614.00K315.00K---6.72M10.01M26.67M23.28M21.92M19.41M17.48M
Net Debt5.72M-6.18M-2.87M-56.22M-65.79M-92.85M-142.95M-196.63M-191.32M-201.95M-208.85M-163.74M-103.57M-94.39M-86.25M

Cash Flow

Currency: USD2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow1.86M4.00M13.47M15.70M38.16M31.03M60.49M59.98M40.59M37.01M23.63M-37.53M-3.23M5.91M-11.22M
Investing Cash Flow-8.92M-12.47M-18.14M-16.25M-29.30M-11.93M-24.43M-24.96M-44.06M-25.64M-14.64M-10.88M-59.31M-13.97M-26.21M
Financing Cash Flow5.18M19.68M3.08M43.87M381.00K7.71M14.00M18.30M4.93M2.07M15.00M380.00K960.00K265.00K24.18M
Capital Expenditure8.96M12.45M18.14M16.24M12.49M8.02M10.23M12.97M6.51M17.34M23.93M21.22M26.52M17.09M10.38M
Free Cash Flow-7.10M-8.44M-4.67M-540.00K25.67M23.02M50.27M47.00M34.08M19.67M-302.00K-58.75M-29.75M-11.18M-21.60M
Dividends Paid---0000--------
FCF to OCF-381.98%-210.89%-34.71%-3.44%67.27%74.17%83.09%78.37%83.95%53.15%-1.28%156.54%919.94%-189.03%192.57%
Dividend Paid to FCF---0.00%0.00%0.00%0.00%--------

Earnings

Report DateMar 27, 2014May 13, 2014Aug 12, 2014Nov 11, 2014Feb 3, 2015May 12, 2015Aug 11, 2015Nov 10, 2015Mar 14, 2016May 9, 2016Aug 4, 2016Nov 3, 2016Feb 28, 2017May 9, 2017Aug 3, 2017Nov 7, 2017Feb 27, 2018Apr 30, 2018Aug 7, 2018Nov 6, 2018Feb 26, 2019May 7, 2019Aug 7, 2019Nov 5, 2019Feb 25, 2020May 5, 2020Aug 4, 2020Nov 4, 2020Feb 24, 2021May 4, 2021Aug 4, 2021Nov 4, 2021Feb 24, 2022May 5, 2022Aug 4, 2022Nov 2, 2022Feb 23, 2023May 4, 2023Aug 7, 2023Nov 7, 2023Feb 27, 2024May 7, 2024Aug 6, 2024Nov 7, 2024Feb 25, 2025May 7, 2025Aug 7, 2025Nov 5, 2025Mar 3, 2026May 7, 2026Aug 6, 2026Nov 4, 2026
EPS Estimate0.020.040.070.060.030.070.140.130.070.120.200.130.110.140.280.290.230.290.440.530.250.330.490.220.10-0.11-0.06-0.09-0.26-0.26-0.10-0.29-0.73-0.51-0.33-0.38-0.57-0.75-0.60-0.23-0.62-0.58-0.39-0.27-0.49-0.25-0.22-0.22-0.34-0.21-0.17-
EPS Actual0.010.050.110.110.060.080.170.130.190.110.250.160.250.270.380.330.310.480.650.730.440.240.450.31-0.06-0.070.12-0.08-0.23-0.030.220.53-1.01-0.62-0.15-0.42-0.20-0.78-0.40-0.36-1.14-0.45-0.07-0.11-0.24-0.11-0.15-0.20-0.15-0.14-0.14-
Surprise-50.00%25.00%57.14%83.33%100.00%14.29%21.43%0.00%171.43%-8.33%25.00%23.08%127.27%92.86%35.71%13.79%34.78%65.52%47.73%37.74%76.00%-27.27%-8.16%40.91%-160.00%36.36%300.00%11.11%11.54%88.46%320.00%282.76%-38.36%-21.57%54.55%-10.53%64.91%-4.00%33.33%-56.52%-83.87%22.41%82.05%59.26%51.02%56.00%31.82%9.09%56.19%33.33%17.65%-
Timing-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-market-After-hoursAfter-hours-

Key Statistics & Ratios

Market Cap142.25M
Enterprise Value45.36M
Trailing P/E0.00
Forward P/E0.00
PEG Ratio3.48
Price / Sales0.40
Price / Book0.77
EPS-0.91
Book Value6.54
Revenue (TTM)354.30M
Gross Profit (TTM)157.69M
EBITDA-8.09M
Profit Margin-6.94%
Operating Margin-5.13%
Return on Equity-13.14%
Return on Assets-5.84%
Shares Outstanding26.54M
Shares Float23.13M
Beta1.58
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 3 analystsTarget 12.00
  • Strong Buy
    1
  • Buy
    1
  • Sell
    1

Ownership Breakdown

Institutions
80.43%
Insiders
12.95%
Retail / Other
6.62%

Top Institutional Holders

  • BlackRock Inc
    1.65M6.21%
  • Armistice Capital, LLC
    1.20M4.52%
  • Acadian Asset Management LLC
    1.08M4.08%
  • Vanguard Capital Management, LLC
    1.04M3.91%
  • Ameriprise Financial Inc
    859.54K3.24%
  • Dafna Capital Management LLC
    845.18K3.18%
  • Point72 Asset Management, L.P.
    642.37K2.42%
  • Geode Capital Management, LLC
    613.53K2.31%
  • Arrowstreet Capital Limited Partnership
    586.16K2.21%
  • The Goldman Sachs Group Inc
    580.10K2.19%
  • State Street Corp
    573.20K2.16%
  • Morgan Stanley - Brokerage Accounts
    541.16K2.04%
  • Federated Hermes Inc
    534.94K2.02%
  • Dimensional Fund Advisors, Inc.
    488.64K1.84%
  • Renaissance Technologies Corp
    478.80K1.80%
  • JPMorgan Chase & Co
    427.66K1.61%
  • AQR Capital Management LLC
    427.12K1.61%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    739.97K2.79%
  • Columbia Small Cap Value Discv A
    644.21K2.43%
  • iShares Russell 2000 ETF
    634.02K2.39%